Apimeds Pharmaceuticals US, Inc.
0 sources
Apimeds Pharmaceuticals US, Inc.
Summary
Key Facts
- Apimeds Pharmaceuticals US, Inc. is in the country of US[1].
- Apimeds Pharmaceuticals US, Inc.'s headquarters location is recorded as Matawan[2].
- Apimeds Pharmaceuticals US, Inc.'s ticker symbol is recorded as APUS[3].
- Apimeds Pharmaceuticals US, Inc.'s stock exchange is recorded as NYSE[4].
- Apimeds Pharmaceuticals US, Inc.'s industry is recorded as Pharmaceutical Preparations[5].
- Apimeds Pharmaceuticals US, Inc.'s official name is recorded as Apimeds Pharmaceuticals US, Inc.[6].
- Apimeds Pharmaceuticals US, Inc.'s 4ort:sic is recorded as 2834[7].
- Apimeds Pharmaceuticals US, Inc.'s 4ort:fiscal_year_end is recorded as 1231[8].
- Apimeds Pharmaceuticals US, Inc.'s 4ort:last_filing_date is recorded as 2026-08-21[9].
- Apimeds Pharmaceuticals US, Inc.'s 4ort:state_of_incorporation is recorded as DE[10].
Body
Identity
Apimeds Pharmaceuticals US, Inc.'s official name is recorded as Apimeds Pharmaceuticals US, Inc.[6].
Operations
Apimeds Pharmaceuticals US, Inc.'s headquarters location is recorded as Matawan[2].
Industry
Apimeds Pharmaceuticals US, Inc.'s industry is recorded as Pharmaceutical Preparations[5].
Ownership
Apimeds Pharmaceuticals US, Inc.'s stock exchange is recorded as NYSE[4].